We use cookies. You have options. Cookies help us keep the site running smoothly and inform some of our advertising, but if you’d like to make adjustments, you can visit our Cookie Notice page for more information.
We’d like to use cookies on your device. Cookies help us keep the site running smoothly and inform some of our advertising, but how we use them is entirely up to you. Accept our recommended settings or customise them to your wishes.
×

Kent Groves, PhD

SVP Client Strategy
Kent Groves

Kent is a Senior Vice President of Strategy and leads Merkle’s Global Health Strategy practice. He has been consulting in the areas of pharmaceutical, provider, and payer strategy for more than 20 years. In addition to broad blog/whitepaper and conference activity, he is published extensively in a variety of journals including, Research in Social and Administrative PharmacyFormulary, the Journal of Clinical Pharmacy and Therapeutics, and the Journal of Database Marketing. ​

Kent has worked with a number of clients in the pharmaceutical, healthcare, and animal health vertical including AbbVie, AstraZeneca, BMS, Boehringer Ingelheim, Novartis, Sanofi (Genzyme, Chattem and Merial), OHSU, Emblem Health, and Anthem, focusing on engagement, communication, and CRM strategy in the US, Canada, Europe, and Australasia. He has a Ph.D. in pharmaceutical strategy and policy from Dalhousie University in Halifax, NS, and holds the position of Assistant Professor, Clinical Pharmacy, at the James L. Winkle College of Pharmacy, University of Cincinnati.

Kent's Articles, Blog Posts, Webinars and More

Blog We suggest...

Leveraging HCP Migration to Optimize Multi-Channel Spend

One of the biggest challenges that launch brands in unique therapeutic areas face is identifying the right target audience for both unbranded and branded messaging. The right audience can impact speed to market, awareness and trial, business impact, and ROI.
Topics: Health